Prospective Pecutaneous Coronary Intervention Registry
Recruiting now
Conditions studied: Coronary Artery Disease, Percutaneous Coronary Intervention
In brief
Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.
Key facts
- Study ID
- NCT05624905
- Run by
- Samsung Medical Center
- People needed
- 15000
- Starts
- 2016-03-20
- Expected to finish
- 2030-12-31
- Last updated by the study team
- 2024-08-14
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention.
You may not qualify if…
- patients who did not consent to the research
Where it is running
- Samsung Medical Center — Seoul, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.